Inhibition of glucocorticoid-induced alteration of vimentin by a glucocorticoid receptor antagonist RU486 in the organ-cultured rat lens
2011

How a Drug Can Prevent Cataracts in Rat Lenses

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Xie Guo-Li, Yan Hong, Lu Zi-Fan

Primary Institution: Fourth Military Medical University

Hypothesis

Can a glucocorticoid receptor antagonist prevent changes in vimentin induced by glucocorticoids in rat lenses?

Conclusion

The glucocorticoid receptor antagonist RU486 can prevent the reduction of vimentin protein expression and the morphological changes in rat lenses induced by dexamethasone.

Supporting Evidence

  • Opacity was observed in the dexamethasone group after 7 days, while the control and RU486+Dex groups remained transparent.
  • Vimentin protein levels decreased in the dexamethasone group compared to the control and RU486+Dex groups.
  • RU486 prevented the morphological changes induced by dexamethasone.

Takeaway

This study shows that a certain drug can stop cataracts from forming in rat lenses by keeping a protein called vimentin at normal levels.

Methodology

Rat lenses were cultured in vitro and treated with dexamethasone or RU486, followed by observation of morphological changes and analysis of vimentin expression.

Limitations

The study was conducted only on rat lenses, which may not fully represent human lens behavior.

Participant Demographics

Three-week-old female Sprague-Dawley rats

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication